We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number : 4131G
GW Pharmaceuticals PLC
22 October 2008
GW Pharmaceuticals plc
Notification of Results
Porton Down, UK, 22 October 2008: GW Pharmaceuticals plc (AIM: GWP) will be announcing its preliminary financial results for the year to
30 September 2008 on Tuesday 18 November 2008.
Enquiries:
Financial Dynamics 020 7831 3113
Ben Atwell
Notes to Editors
About GW
GW was founded in 1998 and listed on the AiM, a market of the London Stock Exchange, in June 2001. Operating under license from the UK
Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious
ailments, in particular pain and other neurological symptoms. GW has assembled a team of over 100 scientists with extensive experience in
developing both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading
position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field.
For further information, please visit the Company's website: www.gwpharm.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORVLLBLVBBXFBV
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
